Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
Frankfurt - Delayed Quote EUR

YSB Inc. (B1S.F)

Compare
0.8000
-0.0100
(-1.23%)
At close: February 21 at 8:04:40 AM GMT+1
Loading Chart for B1S.F
DELL
  • Previous Close 0.8100
  • Open 0.8000
  • Bid 0.8050 x --
  • Ask 0.8600 x --
  • Day's Range 0.8000 - 0.8000
  • 52 Week Range 0.6350 - 0.9800
  • Volume 0
  • Avg. Volume 0
  • Market Cap (intraday) 564.807M
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) 0.39
  • EPS (TTM) 2.0300
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

YSB Inc. develops digital pharmaceutical platform for pharmaceutical companies, distributors, vendors, pharmacies, and primary healthcare institutions in China. The company develops ClouDiagnos for diagnostic testing service; wePharmacy, a 24-hour access smart unmanned pharmaceutical booth that connects buyers and the end customers with pharmacist services; SaaS solutions; and YSB eLearn that provides online courses for the preparation of the pharmacist qualification examinations. It also engages in the wholesale and retail of pharmaceutical and healthcare products. In addition, the company provides medical testing services. YSB Inc. was founded in 2015 and is headquartered in Guangzhou, China.

www.ysbang.cn

6,513

Full Time Employees

December 31

Fiscal Year Ends

Recent News: B1S.F

View More

Performance Overview: B1S.F

Trailing total returns as of 2/21/2025, which may include dividends or other distributions. Benchmark is

.

YTD Return

B1S.F
17.65%
HANG SENG INDEX
17.04%

1-Year Return

B1S.F
18.37%
HANG SENG INDEX
42.26%

3-Year Return

B1S.F
18.37%
HANG SENG INDEX
2.86%

5-Year Return

B1S.F
18.37%
HANG SENG INDEX
14.03%

Compare To: B1S.F

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: B1S.F

View More

Valuation Measures

Annual
As of 2/21/2025
  • Market Cap

    560.64M

  • Enterprise Value

    292.74M

  • Trailing P/E

    0.39

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.22

  • Price/Book (mrq)

    2.04

  • Enterprise Value/Revenue

    0.13

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.01%

  • Return on Assets (ttm)

    -1.36%

  • Return on Equity (ttm)

    -0.88%

  • Revenue (ttm)

    17.82B

  • Net Income Avi to Common (ttm)

    1.2M

  • Diluted EPS (ttm)

    2.0300

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    2.26B

  • Total Debt/Equity (mrq)

    10.84%

  • Levered Free Cash Flow (ttm)

    387.2M

Research Analysis: B1S.F

View More

Company Insights: B1S.F

Research Reports: B1S.F

View More